Johnson & Johnson Ordered to Pay $45 Million in Talcum Powder Lawsuit, Faces Ongoing Legal Battles
ICARO Media Group
The family alleged that the product led to the death of a relative diagnosed with a fatal cancer linked to asbestos exposure. This legal issue adds to Johnson & Johnson's ongoing challenges surrounding their talc products.
However, the company received a favorable outcome in a similar lawsuit in a Florida court a day prior. The jury in that case determined that Johnson & Johnson's baby powder did not cause the ovarian cancer diagnosis of a woman who had used the product daily and tragically passed away in 2019 after being diagnosed in 2016.
Johnson & Johnson has consistently maintained that their talc-based baby powder does not contain asbestos and does not cause cancer. In August 2022, the company announced its plans to replace talc with cornstarch in its products worldwide, starting in 2023. These changes were preceded by the discontinuation of talc-based products in North America in 2020 due to declining sales.
The Justice Department launched an investigation into Johnson & Johnson's talc products in July 2019, focusing on what the company knew about the potential cancer risks. The company has faced thousands of lawsuits alleging talc-induced health problems, leading to two bankruptcy filings in October 2021 and April 2023. However, a proposed $8.9 billion settlement to resolve claims brought by thousands of plaintiffs was rejected by a judge in July.
As of December 2023, Johnson & Johnson is faced with over 50,000 lawsuits linked to its talcum-based baby powder, according to Reuters. In January, the company reportedly entered a tentative agreement involving a payment of $700 million for the marketing of its talcum baby powder, following investigations from more than 400 states and numerous lawsuits.
The legal battles surrounding Johnson & Johnson's talcum powder products continue as the company faces significant scrutiny and financial implications. The outcomes of these lawsuits will have far-reaching implications for both the company and the individuals affected by the alleged health risks associated with talc-based products.